Compound Detail
CHEMBL3643413
LENIOLISIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3643413 |
| Name | LENIOLISIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MWKYMZXCGYXLPL-ZDUSSCGKSA-N |
| Therapeutic | ✓ Yes |
20
Targets
53
Activities
2
Assay Types
16
PK Parameters
20
Publications
5
Known Names
1
Indications
1
Mechanisms
Molecular Properties
450.5
MW (Da)
2.88
ALogP
7
HBA
1
HBD
83.5
PSA (Ų)
0.75
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| PI3-kinase p110-delta subunit inhibitor | INHIBITOR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | ✓ | ✓ |
Indications
Neoplasms
ATC Classification
L03AX22
leniolisib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSTIMULANTS
Activity Summary
IC50 50 meas. best 8.82
EC50 3 meas. best 7.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform CHEMBL3130 | IC50 | 8.82 | 7.222 | 1.5 | 15 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform CHEMBL2216745 | IC50 | 8.15 | 7.59 | 7.0 | 5 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform CHEMBL4005 | IC50 | 7.12 | 6.5225 | 75.5 | 4 |
| Rattus norvegicus CHEMBL376 | EC50 | 7.08 | 7.08 | 83.0 | 1 |
| Cynomolgus monkey CHEMBL613847 | IC50 | 7.08 | 7.08 | 84.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 7.08 | 6.965 | 83.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 7.0 | 6.94 | 99.0 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform CHEMBL3145 | IC50 | 6.44 | 6.0075 | 363.0 | 4 |
| SU-DHL-6 CHEMBL4296496 | IC50 | 6.11 | 6.11 | 770.0 | 1 |
| DNA-dependent protein kinase catalytic subunit CHEMBL3142 | IC50 | 6.06 | 6.06 | 880.0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform CHEMBL3267 | IC50 | 6.04 | 5.845 | 902.0 | 2 |
| Rec1 CHEMBL4483266 | IC50 | 5.89 | 5.89 | 1280.0 | 1 |
| Pfeiffer CHEMBL4296489 | IC50 | 5.43 | 5.43 | 3750.0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform CHEMBL2189158 | IC50 | 5.39 | 5.25 | 4037.4 | 2 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 5.33 | 5.33 | 4700.0 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 5.11 | 5.11 | 7700.0 | 2 |
| SUD4 CHEMBL613711 | IC50 | 5.08 | 5.08 | 8250.0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform CHEMBL2499 | IC50 | 4.71 | 4.71 | 19628.2 | 1 |
| DOHH-2 CHEMBL2366181 | IC50 | 4.54 | 4.54 | 29200.0 | 1 |
| Z-138 CHEMBL4483276 | IC50 | 4.51 | 4.51 | 31190.0 | 1 |
| JeKo-1 CHEMBL4296445 | IC50 | 4.5 | 4.5 | 31660.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 28.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 2.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 17.0 | mL.min-1.kg-1 | Macaca fascicularis |
| CL | 355.01 | mL.min-1.kg-1 | Mus musculus |
| F | 86.0 | % | Rattus norvegicus |
| F | 100.0 | % | Rattus norvegicus |
| F | 58.0 | % | Canis lupus familiaris |
| F | 13.0 | % | Macaca fascicularis |
| T1/2 | 1.8 | hr | Rattus norvegicus |
| T1/2 | 1.5 | hr | Canis lupus familiaris |
| T1/2 | 0.7 | hr | Macaca fascicularis |
| T1/2 | 0.2562 | hr | Mus musculus |
| Tmax | 0.4 | hr | Rattus norvegicus |
| Tmax | 0.25 | hr | Rattus norvegicus |
| Tmax | 0.7 | hr | Canis lupus familiaris |
| Tmax | 0.5 | hr | Macaca fascicularis |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine